These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31345150)

  • 1. High Contrast and Resolution Labeling of Amyloid Plaques in Tissue Sections from APP-PS1 Mice and Humans with Alzheimer's Disease with the Zinc Chelator HQ-O: Practical and Theoretical Considerations.
    Schmued L; Raymick J; Sarkar S
    Curr Alzheimer Res; 2019; 16(7):577-586. PubMed ID: 31345150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a stable and solvent-soluble variant of Amylo-Glo, Amylo-Glo+, for the high-contrast and resolution fluorescent localization of amyloid plaques in murine and human brain tissue sections.
    Schmued L
    J Neurosci Methods; 2022 Jan; 365():109381. PubMed ID: 34662590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing Euro-Glo, a rare earth metal chelate with numerous applications for the fluorescent localization of myelin and amyloid plaques in brain tissue sections.
    Schmued L; Raymick J
    J Neurosci Methods; 2017 Mar; 279():79-86. PubMed ID: 27939963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.
    Meadowcroft MD; Connor JR; Smith MB; Yang QX
    J Magn Reson Imaging; 2009 May; 29(5):997-1007. PubMed ID: 19388095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer's disease.
    Park YD; Park JH; Hur MG; Kim SW; Min JJ; Park SH; Yoo YJ; Yoon YJ; Yang SD
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4106-10. PubMed ID: 22578456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing Amylo-Glo, a novel fluorescent amyloid specific histochemical tracer especially suited for multiple labeling and large scale quantification studies.
    Schmued L; Raymick J; Tolleson W; Sarkar S; Zhang YH; Bell-Cohn A
    J Neurosci Methods; 2012 Jul; 209(1):120-6. PubMed ID: 22705750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of boronic acid-based fluorescent probes targeting amyloid-beta plaques in Alzheimer's disease.
    Jung SJ; Lee JY; Kim TH; Lee DE; Jeon J; Yang SD; Hur MG; Min JJ; Park YD
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1784-8. PubMed ID: 26927427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
    James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
    ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a brain permeant fluorescent molecule and visualization of Aβ parenchymal plaques, using real-time multiphoton imaging in transgenic mice.
    Sundaram GS; Garai K; Rath NP; Yan P; Cirrito JR; Cairns NJ; Lee JM; Sharma V
    Org Lett; 2014 Jul; 16(14):3640-3. PubMed ID: 25003699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease.
    Jung SJ; Park SH; Lee EJ; Park JH; Kong YB; Rho JK; Hur MG; Yang SD; Park YD
    Arch Pharm Res; 2015 Nov; 38(11):1992-8. PubMed ID: 26012373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of methods to use Congo-red stain to simultaneously visualize amyloid plaques and tangles in human and rodent brain tissue sections.
    Sarkar S; Raymick J; Cuevas E; Rosas-Hernandez H; Hanig J
    Metab Brain Dis; 2020 Dec; 35(8):1371-1383. PubMed ID: 32852699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques.
    Ran K; Yang J; Nair AV; Zhu B; Ran C
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32079064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal chelator decreases Alzheimer beta-amyloid plaques.
    Gouras GK; Beal MF
    Neuron; 2001 Jun; 30(3):641-2. PubMed ID: 11430794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.
    Dhenain M; Delatour B; Walczak C; Volk A
    Magn Reson Med; 2006 Mar; 55(3):687-93. PubMed ID: 16470593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin.
    Maiti P; Plemmons A; Bowers Z; Weaver C; Dunbar G
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice.
    Sarkar S; Raymick J; Ray B; Lahiri DK; Paule MG; Schmued L
    Curr Alzheimer Res; 2015; 12(9):837-46. PubMed ID: 26510980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice.
    Bigot C; Vanhoutte G; Verhoye M; Van der Linden A
    Neuroimage; 2014 Feb; 87():111-9. PubMed ID: 24188815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel fluorescent probe for the sensitive detection of β-amyloid deposits.
    Ren W; Xu M; Liang SH; Xiang H; Tang L; Zhang M; Ding D; Li X; Zhang H; Hu Y
    Biosens Bioelectron; 2016 Jan; 75():136-41. PubMed ID: 26313423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.